Similarly, ceramides decreased in the CP group, while sphingomyelin, sphingolipids, diacylglycerol, triglycerides, ether phosphatidylcholine, ether phosphatidylcholine, and lysophosphatidylcholine increased (Figure 3A), and in the QYKL group, these lipid compounds had varying degrees of correction (Figure 6F), thus improving lipid metabolism disorders. Here, CP is linked to Disorder of lipid metabolism.